Steve O'Loughlin

VP, Corp Finance & Development, Protea Biosciences Group, Inc.

Companies

CNS Pharmaceuticals, Inc.Chief financial officer Mar 4, 2026 to now¹
Actinium Pharmaceuticals, Inc.Chief financial officer Aug 14, 2020 to now²
Actinium Pharmaceuticals, Inc.Board member Jul 1, 2022 to Jul 1, 2022³
Actinium Pharmaceuticals, Inc.VP, Finance and Corporate Dev. May 17, 2017 to Jul 16, 2019⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCNS Pharmaceuticals, Inc., Chief financial officer
2
SEC EDGARActinium Pharmaceuticals, Inc., Chief financial officer
3
SEC EDGARActinium Pharmaceuticals, Inc., Board member
4
SEC EDGARActinium Pharmaceuticals, Inc., VP, Finance and Corporate Dev.